{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T20:23:32Z","timestamp":1770063812810,"version":"3.49.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2006,1,1]],"date-time":"2006-01-01T00:00:00Z","timestamp":1136073600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,1,1]],"date-time":"2006-01-01T00:00:00Z","timestamp":1136073600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Heart Journal"],"published-print":{"date-parts":[[2006,1]]},"DOI":"10.1016\/j.ahj.2005.03.054","type":"journal-article","created":{"date-parts":[[2005,12,22]],"date-time":"2005-12-22T18:08:02Z","timestamp":1135274882000},"page":"55-61","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Are \u03b2-blockers needed in patients receiving spironolactone for severe chronic heart failure? An analysis of the COPERNICUS study"],"prefix":"10.1016","volume":"151","author":[{"given":"Henry","family":"Krum","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Mohacsi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hugo A.","family":"Katus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Tendera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Lucien","family":"Rouleau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael B.","family":"Fowler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew J.","family":"Coats","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ellen B.","family":"Roecker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Milton","family":"Packer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ahj.2005.03.054_bib1","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1056\/NEJM200105313442201","article-title":"Effect of carvedilol on survival in severe chronic heart failure","volume":"344","author":"Packer","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2005.03.054_bib2","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0140-6736(98)11181-9","article-title":"The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial","volume":"353","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.ahj.2005.03.054_bib3","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1016\/S0140-6736(99)04440-2","article-title":"Metoprolol CR\/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF) Study. Effect of metoprolol CR\/XL in chronic heart failure","volume":"353","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.ahj.2005.03.054_bib4","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1056\/NEJM199605233342101","article-title":"The effect of carvedilol on morbidity and mortality in patients with chronic heart failure","volume":"334","author":"Packer","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2005.03.054_bib5","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJM199909023411001","article-title":"The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators","volume":"341","author":"Pitt","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2005.03.054_bib6","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1056\/NEJMoa030207","article-title":"Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction","volume":"348","author":"Pitt","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2005.03.054_bib7","doi-asserted-by":"crossref","first-page":"2194","DOI":"10.1161\/01.CIR.0000035653.72855.BF","article-title":"Effect of carvedilol on the morbidity of patients with severe chronic heart failure: results of the Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) study","volume":"106","author":"Packer","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2005.03.054_bib8","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1016\/j.jacc.2003.11.037","article-title":"Influence of pretreatment systolic blood pressure on the effect of carvedilol in patients with severe chronic heart failure: the COPERNICUS Study","volume":"43","author":"Rouleau","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2005.03.054_bib9","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0306-3623(97)00396-0","article-title":"Effects of spironolactone on exercise capacity and neurohormonal factors in patients with heart failure treated with loop diuretics and angiotensin-converting enzyme inhibitor","volume":"31","author":"Kinugawa","year":"1998","journal-title":"Gen Pharmacol"},{"key":"10.1016\/j.ahj.2005.03.054_bib10","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1042\/cs0950687","article-title":"Aldosterone blunts the baroreflex response in man","volume":"95","author":"Yee","year":"1998","journal-title":"Clin Sci (Lond)"},{"key":"10.1016\/j.ahj.2005.03.054_bib11","doi-asserted-by":"crossref","first-page":"H2241","DOI":"10.1152\/ajpheart.2001.281.5.H2241","article-title":"Central mineralocorticoid receptor blockade improves volume regulation and reduces sympathetic drive in heart failure","volume":"281","author":"Francis","year":"2001","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.ahj.2005.03.054_bib12","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/S0735-1097(02)02855-3","article-title":"Effect of spironolactone on cardiac sympathetic nerve activity and left ventricular remodeling in patients with dilated cardiomyopathy","volume":"41","author":"Kasama","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2005.03.054_bib13","doi-asserted-by":"crossref","first-page":"2694","DOI":"10.1161\/01.CIR.99.20.2694","article-title":"Activation of cardiac aldosterone production in rat myocardial infarction: effect of angiotensin II receptor blockade and role in cardiac fibrosis","volume":"99","author":"Silvestre","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2005.03.054_bib14","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/S0008-6363(03)00251-7","article-title":"Aldosterone receptor blockade improves left ventricular remodeling and increases ventricular fibrillation threshold in experimental heart failure","volume":"58","author":"Cittadini","year":"2003","journal-title":"Cardiovasc Res"},{"issue":"1 Suppl 1","key":"10.1016\/j.ahj.2005.03.054_bib15","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0033-0620(98)80031-5","article-title":"Use of carvedilol in chronic heart failure: challenges in therapeutic management","volume":"41","author":"Sackner-Bernstein","year":"1998","journal-title":"Prog Cardiovasc Dis"},{"key":"10.1016\/j.ahj.2005.03.054_bib16","doi-asserted-by":"crossref","first-page":"23F","DOI":"10.1016\/0002-9149(86)90884-2","article-title":"Epinephrine-induced hypokalemia: the role of beta adrenoceptors","volume":"57","author":"Reid","year":"1986","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ahj.2005.03.054_bib17","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1159\/000183809","article-title":"Beta adrenergic control of extrarenal potassium disposal. A beta-2 mediated phenomenon","volume":"43","author":"Bia","year":"1986","journal-title":"Nephron"},{"key":"10.1016\/j.ahj.2005.03.054_bib18","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1046\/j.1365-2796.2001.00786.x","article-title":"Marked suppression of renin levels by beta-receptor blocker in patients treated with standard heart failure therapy: a potential mechanism of benefit from beta-blockade","volume":"249","author":"Holmer","year":"2001","journal-title":"J Intern Med"},{"key":"10.1016\/j.ahj.2005.03.054_bib19","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1124\/jpet.102.040956","volume":"304","author":"Makino","year":"2003","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.ahj.2005.03.054_bib20","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1161\/01.RES.66.3.662","article-title":"Importance of endogenous angiotensin II in the cardiovascular responses to sympathetic stimulation in conscious rabbits","volume":"66","author":"Isaacson","year":"1990","journal-title":"Circ Res"},{"key":"10.1016\/j.ahj.2005.03.054_bib21","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1161\/01.HYP.0000028001.65341.AA","article-title":"Angiotensin II induces catecholamine release by direct ganglionic excitation","volume":"40","author":"Dendorfer","year":"2002","journal-title":"Hypertension"},{"key":"10.1016\/j.ahj.2005.03.054_bib22","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1161\/01.HYP.0000047513.75459.7E","article-title":"Modulation of angiotensin II responses in sympathetic neurons by cytosolic calcium","volume":"41","author":"Fernandez","year":"2003","journal-title":"Hypertension"},{"key":"10.1016\/j.ahj.2005.03.054_bib23","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1007\/s007020050185","article-title":"Facilitation of sympathetic neurotransmission contributes to angiotensin regulation of body weight","volume":"106","author":"English","year":"1999","journal-title":"J Neural Transm"},{"key":"10.1016\/j.ahj.2005.03.054_bib24","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/S0008-6363(99)00174-1","article-title":"Angiotensin II modulates conducted vasoconstriction to norepinephrine and local electrical stimulation in rat mesenteric arterioles","volume":"44","author":"Gustafsson","year":"1999","journal-title":"Cardiovasc Res"},{"issue":"Suppl 2","key":"10.1016\/j.ahj.2005.03.054_bib25","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1007\/s003950050202","article-title":"Interactions between the renin-angiotensin system (RAS) and the sympathetic system","volume":"93","author":"Dendorfer","year":"1998","journal-title":"Basic Res Cardiol"},{"key":"10.1016\/j.ahj.2005.03.054_bib26","doi-asserted-by":"crossref","first-page":"S165","DOI":"10.1097\/00004872-199212000-00018","article-title":"Vascular tissue renin-angiotensin system in hypertensive humans","volume":"10","author":"Taddei","year":"1992","journal-title":"J Hypertens"},{"key":"10.1016\/j.ahj.2005.03.054_bib27","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1161\/01.CIR.0000092166.30360.78","article-title":"Dual inhibition of beta-adrenergic and angiotensin II receptors by a single antagonist: a functional role for receptor-receptor interaction in vivo","volume":"108","author":"Barki-Harrington","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2005.03.054_bib28","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1056\/NEJM199209033271001","article-title":"Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial","volume":"3","author":"Pfeffer","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2005.03.054_bib29","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/S0140-6736(00)04560-8","article-title":"Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: the CAPRICORN randomised trial","volume":"357","author":"Dargie","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.ahj.2005.03.054_bib30","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1056\/NEJM200105313442202","article-title":"A trial of the beta-blocker bucindolol in patients with advanced chronic heart failure","volume":"344","author":"Beta-Blocker Evaluation of Survival Trial Investigators","year":"2001","journal-title":"N Engl J Med"}],"container-title":["American Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000287030500356X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000287030500356X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T05:17:53Z","timestamp":1757567873000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000287030500356X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,1]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2006,1]]}},"alternative-id":["S000287030500356X"],"URL":"https:\/\/doi.org\/10.1016\/j.ahj.2005.03.054","relation":{},"ISSN":["0002-8703"],"issn-type":[{"value":"0002-8703","type":"print"}],"subject":[],"published":{"date-parts":[[2006,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Are \u03b2-blockers needed in patients receiving spironolactone for severe chronic heart failure? An analysis of the COPERNICUS study","name":"articletitle","label":"Article Title"},{"value":"American Heart Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ahj.2005.03.054","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2005 Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}